These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6304745)

  • 21. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H; Triolo J; Lefer AM
    Circ Shock; 1987; 21(4):271-83. PubMed ID: 3581442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of the action of opiate receptor antagonists in acute shock-induced blood loss].
    Sherman DM; Lafarenko VA
    Eksp Klin Farmakol; 1998; 61(1):25-9. PubMed ID: 9575407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
    Sturniolo R; Squadrito F; Campo GM; Vinci R; Calatroni A; Prosdocimi M; Caputi AP
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):261-6. PubMed ID: 1709231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
    Bitterman H; Stahl GL; Terashita Z; Lefer AM
    Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of suppression of endocrine or exocrine pancreatic function in hemorrhagic shock.
    Galvin MJ; Lefer AM
    Experientia; 1979 Jan; 35(1):55-6. PubMed ID: 369876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of opiate receptor agonists on the blood circulation in rats with hemorrhagic shock].
    Slepushkin VD; Grossler Iu; Sheĭkh DV
    Patol Fiziol Eksp Ter; 1990; (4):18-20. PubMed ID: 1964205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats.
    Trachte GJ; Lefer AM
    Circ Res; 1978 Oct; 43(4):576-82. PubMed ID: 210975
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril and the intestinal response to hemorrhagic shock.
    Rosenfeld LM; Cooper HS
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):144-52. PubMed ID: 6758718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mu-opioid activity of kappa-opioid receptor agonist compounds in the guinea pig ileum.
    Berzetei-Gurske IP; Toll L
    Eur J Pharmacol; 1992 Mar; 212(2-3):283-6. PubMed ID: 1318215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrocortical and medullary blood flow changes after general opiate receptor blockade during hemorrhagic shock in cats.
    Komjáti K; Sandor P; Sandor N; Szirmai L; H-Velkei M; Kovach AG
    Shock; 1997 Apr; 7(4):288-93. PubMed ID: 9110415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.